810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC).
Conference Paper
Full Text
Duke Authors
Cited Authors
- Motzer, RJ; Rini, BI; McDermott, DF; Redman, B; Kuzel, T; Harrison, MR; Vaishampayan, UN; Drabkin, H; George, S; Logan, T; Margolin, K; Plimack, ER; Waxman, I; Lambert, A; Hammers, H
Published Date
- September 1, 2014
Published In
Volume / Issue
- 25 / suppl_4
Start / End Page
- iv281 -
PubMed ID
- 28172310
Electronic International Standard Serial Number (EISSN)
- 1569-8041
Digital Object Identifier (DOI)
- 10.1093/annonc/mdu337.3
Conference Location
- England